Embla Medical hf Logo

Embla Medical hf

Global provider of non-invasive orthopedics, prosthetics, and mobility solutions.

EMBLA | CO

Overview

Corporate Details

ISIN(s):
IS0000000040
LEI:
213800K2AVTAFWJ4DP64
Country:
Iceland
Address:
5 GRJOTHALS, 110 REYKJAVIK
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Embla Medical hf, formerly Össur hf, is a leading global provider of non-invasive orthopedic products and innovative mobility solutions. The company's primary business segments include Prosthetics, Neuro Orthotics, and Bracing & Supports. Embla Medical operates as the parent organization for a portfolio of product brands, including Össur, College Park, and FIOR & GENTZ. In addition to developing and manufacturing products, the company provides patient services through a global network of Orthotic & Prosthetic (O&P) care facilities. The company's stated mission is to help people live a "Life Without Limitations" by enhancing mobility and well-being through its comprehensive offerings.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-17 17:00
Regulatory News Service
English 290.9 KB
2025-11-17 17:00
Transaction in Own Shares
English 19.4 KB
2025-11-10 17:00
Transaction in Own Shares
English 19.4 KB
2025-11-10 17:00
Regulatory News Service
English 170.6 KB
2025-11-03 17:00
Transaction in Own Shares
English 19.5 KB
2025-11-03 17:00
Transaction in Own Shares
English 104.6 KB
2025-10-27 17:00
Transaction in Own Shares
English 105.9 KB
2025-10-27 17:00
Transaction in Own Shares
English 19.4 KB
2025-10-21 07:00
Quarterly Report
English 600.6 KB
2025-10-21 07:00
Earnings Release
English 18.8 KB
2025-10-20 17:00
Transaction in Own Shares
English 19.4 KB
2025-10-20 17:00
Transaction in Own Shares
English 122.7 KB
2025-10-13 17:00
Transaction in Own Shares
English 19.4 KB
2025-10-13 17:00
Transaction in Own Shares
English 118.3 KB
2025-10-06 17:00
Transaction in Own Shares
English 19.4 KB

Automate Your Workflow. Get a real-time feed of all Embla Medical hf filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Embla Medical hf

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Embla Medical hf via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bone Biologics Corp Logo
Developing a protein-based bone graft for targeted bone regeneration in spinal fusion.
United States of America
BBLG
Bonesupport Holding Logo
Develops & markets injectable bioceramic bone grafts that remodel into bone to heal fractures.
Sweden
BONEX
Bonyf N.V. Logo
Develops patented oral, dental, and dermatological care products for consumers and professionals.
Belgium
MLBON
BOSTON SCIENTIFIC CORP Logo
Develops innovative, less-invasive medical devices for various interventional specialties.
United States of America
BSX
Boule Diagnostics Logo
Global provider of complete hematology systems for human and veterinary diagnostics.
Sweden
BOUL
BrainCool AB Logo
Develops medical cooling systems to protect the brain after cardiac arrest, stroke, or injury.
Sweden
BRAIN
CARLSMED, INC. Logo
AI-driven planning and patient-specific 3D-printed implants for spinal fusion surgery.
United States of America
CARL
Carl Zeiss Meditec AG Logo
Develops medical tech for ophthalmology & microsurgery, from diagnostics to surgical systems.
Germany
AFX
CARMAT Logo
Develops an implantable artificial heart as a bridge-to-transplant for heart failure patients.
France
ALCAR
CASTLE BIOSCIENCES INC Logo
Provides genomic tests for dermatologic cancers to guide personalized treatment decisions.
United States of America
CSTL

Talk to a Data Expert

Have a question? We'll get back to you promptly.